Patents by Inventor Fredrik Jerneren

Fredrik Jerneren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210196663
    Abstract: The present invention provides a combined therapy comprising the use of one or more omega-3 fatty acids and one or more B vitamins and for treating cognitive impairment, such cognitive impairment disorders include, especially but not exclusively, Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The present invention also provides a treatment for individuals suffering from cognitive impairment disorders that occur as a result of brain or cerebral atrophy, the invention includes inter alia methods of treating and/or reducing progression of brain atrophy and pharmaceutical compositions and nutritional supplements therefor.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 1, 2021
    Inventors: David Smith, Fredrik Jerneren, Helga Refsum
  • Patent number: 10966947
    Abstract: The present invention provides a combined therapy comprising the use of one or more omega-3 fatty acids and one or more B vitamins and for treating cognitive impairment, such cognitive impairment disorders include, especially but not exclusively, Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The present invention also provides a treatment for individuals suffering from cognitive impairment disorders that occur as a result of brain or cerebral atrophy, the invention includes inter alma methods of treating and/or reducing progression of brain atrophy and pharmaceutical compositions and nutritional supplements therefor.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: April 6, 2021
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: David Smith, Fredrik Jerneren, Helga Refsum
  • Publication number: 20180169048
    Abstract: The present invention provides a combined therapy comprising the use of one or more omega-3 fatty acids and one or more B vitamins and for treating cognitive impairment, such cognitive impairment disorders include, especially but not exclusively, Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The present invention also provides a treatment: for individuals suffering from cognitive impairment disorders that occur as a result of brain or cerebral atrophy, the invention includes inter alma methods of treating and/or reducing progression of brain atrophy and pharmaceutical compositions and nutritional supplements therefor.
    Type: Application
    Filed: March 17, 2015
    Publication date: June 21, 2018
    Inventors: David Smith, Fredrik Jerneren, Helga Refsum